The top Senate Republican struggled to salvage major health-care legislation sought by President Trump. » Read More
By: Dan Mangan
Shkreli is accused of looting his former drug company Retrophin to pay off investors he allegedly defrauded at two hedge funds he ran. » Read More
By: Robert Frank
The Senate health-care bill would give the wealthy the biggest tax break in over a decade, according to an analysis. » Read More
By: Dylan Matthews
Here's one idea for universal coverage that doesn't require sudden massive tax increases, says Dylan Matthews. » Read More
House Republicans are pushing for a vote Thursday on a bill to repeal and replace Obamacare.
U.S. Secretary of Health and Human Services Tom Price makes a plea for passage of Obamacare repeal and replacement on eve of expected vote in the House of Representatives.
All it took was adding a few billion dollars to the bill, to provide cover to moderate lawmakers who had been reluctant to support it. Vox reports.
Aetna announced earlier this year that it was exiting Iowa's market in 2018.
Price increases for a small fraction of brand-name drugs with no generic alternatives fueled the big increase in spending.
The Republican health-care reform bill has been stalled in the House for almost two months.
Kimmel's emotional remarks underscore the concerns that have kept some Republicans from voting for a GOP Obamacare replacement bill.
The GOP's health-care bill — and the party's candidates for 2018 — get less attractive with every revision, Chris Pope writes in the National Review.
As awareness of conflicts of interest in medicine grows, so does accountability over how they affect prescribing, ProPublica reports.
House Republicans and the White House are working to shore up enough votes on their health care bill even as the prospect of passing a bill looks daunting.
Aetna has pulled out of all but four state Obamacare marketplaces because of financial losses.
The loss of Rep. Fred Upton's vote will make it even harder for the GOP to win passage of the already controversial bill.
Former FDA commissioner Dr. Robert Califf's successor, Dr. Scott Gottlieb, awaits confirmation from the full Senate.
Philips CEO Frans Van Houten speaks to CNBC about the investment its company is making in health technology.
Jimmy Kimmel gave an emotional account of how his newborn son was diagnosed with a rare heart condition and almost died. NBCNews reports.
Drugmaker Pfizer reported a 2.7 percent rise in quarterly profit, helped by higher sales of breast cancer drug Ibrance.
The news comes at a time when health-care companies and hospitals are seesawing on President Donald Trump's every word about the industry.
Merck reported a 1.3 percent rise in quarterly revenue, helped by higher demand for its key immuno-oncology drug Keytruda.
Aetna reported better-than-expected earnings, helped by strength in the health insurer's commercial and government unit.
A project to make synthetic human DNA is in the early stages, but could be within humans to fight disease in less than five years.
Get the best of CNBC in your inbox